Table 3B.
Intervention effects from linear mixed model of the clinical secondary outcome.
| Overall effect |
Visit 2 |
Visit 3 |
||||
|---|---|---|---|---|---|---|
| Difference (95% CI) | p-value | Difference (95% CI) | p-value | Difference (95% CI) | p-value | |
| Systolic blood pressure | ||||||
| Crudea | 1.32 (–2.83 to 5.47) | 0.533 | 2.14 (–2.78 to 7.07) | 0.394 | 0.30 (–5.03 to 5.62) | 0.913 |
| Adjustedb | 1.52 (–2.71 to 5.75) | 0.481 | 2.30 (–2.69 to 7.29) | 0.366 | 0.56 (–4.83 to 5.96) | 0.838 |
| Diastolic blood pressure | ||||||
| Crude | 0.93 (–2.30 to 4.15) | 0.573 | 1.79 (–1.90 to 5.48) | 0.342 | –0.17 (–4.13 to 3.79) | 0.932 |
| Adjusted | 0.63 (–2.65 to 3.92) | 0.706 | 1.49 (–2.25 to 5.23) | 0.435 | –0.46 (–4.47 to 3.55) | 0.822 |
CI, confidence interval. aCorrected for baseline value of the particular outcome. bAdditionally corrected for MARS-5 score at baseline and possible confounders age, gender and education level.